Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 24 Genitourinary 11 Other hematologic neoplasm 6 Breast 6 Gynecologic 5 Thoracic 2 Plasma cell 2 Lymphoid 2 Head & Neck 2 Other 1 NET 1 Myeloid 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 377 Carcinoid Tumor 40 Gastro-enteropancreatic neuroendocrine tumor 36 Pancreatic Neoplasms 27 Carcinoma, Neuroendocrine 27 Neoplasms 25 Adenoma, Islet Cell 23 Neoplasm Metastasis 17 Pheochromocytoma 16 Paraganglioma 16 Stomach Neoplasms 15 Neuroblastoma 14 Gastrointestinal Neoplasms 14 Carcinoma, Hepatocellular 12 Thyroid Neoplasms 11 Prostatic Neoplasms 11 Breast Neoplasms 11 Sarcoma 10 Esophageal Neoplasms 10 Colorectal Neoplasms 10 Lung Neoplasms 9 Rectal Neoplasms 8 Gastrointestinal Stromal Tumors 8 Cholangiocarcinoma 8 Carcinoma 8 Brain Neoplasms 8 Anus Neoplasms 8 Liver Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Medullary 7

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Frailty × NET × Clear all

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡